Sun Pharma May Test Rs 760-780 on Downside: Aditya Agarwal
Aditya Agarwal, head technical research at Way2wealth, says Sun Pharma has closed below a crucial support at Rs 820 and selling pressure in the stock may continue going ahead. The shares may test Rs 780 levels in the short term, he adds.
![Gadgets 360 With Technical Guruji: News of the Week [July 5, 2025]](https://c.ndtvimg.com/2025-07/on2ghsbc_news-of-the-week_160x120_05_July_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: News of the Week [July 5, 2025]")
